EU-funded consortium Exscalate4CoV announced today that an already registered generic drug used to treat osteoporosis, Raloxifene, could be an effective treatment for milder symptoms of Covid19, to halt the spread of infection. The consortium is using an EU-backed supercomputing platform, one of the world’s most powerful platforms, to check the potential impact of known molecules against the coronavirus.

For more information

Using European supercomputing, the coordinator of an EU-funded research project announces promising results for potential treatment

European supercomputers join pharmaceutical companies in hunt for coronavirus drug

Using European supercomputing to treat the coronavirus